Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Babcock & Wilcox Enterprises (BWNB) Cash & Equivalents (2016 - 2024)

Babcock & Wilcox Enterprises' Cash & Equivalents history spans 12 years, with the latest figure at $26.9 million for Q4 2024.

  • For Q4 2024, Cash & Equivalents fell 58.9% year-over-year to $26.9 million; the TTM value through Dec 2024 reached $26.9 million, down 58.9%, while the annual FY2024 figure was $26.9 million, 58.9% down from the prior year.
  • Cash & Equivalents reached $26.9 million in Q4 2024 per BWNB's latest filing, down from $63.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $224.9 million in Q4 2021 to a low of $6.5 million in Q3 2023.
  • Average Cash & Equivalents over 5 years is $50.9 million, with a median of $48.2 million recorded in 2020.
  • Peak YoY movement for Cash & Equivalents: soared 2129.79% in 2021, then tumbled 83.59% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $10.1 million in 2020, then skyrocketed by 2129.79% to $224.9 million in 2021, then crashed by 65.88% to $76.7 million in 2022, then fell by 14.85% to $65.3 million in 2023, then tumbled by 58.9% to $26.9 million in 2024.
  • Per Business Quant, the three most recent readings for BWNB's Cash & Equivalents are $26.9 million (Q4 2024), $63.4 million (Q3 2024), and $95.5 million (Q2 2024).